Terlipressin - TERLIVAZ IV injection

Days 1-3: 0.85 mg IV every 6 hours over 2 minutes. On day 4, stop if SCr is at or above baseline; if SCr has fallen by at least 30%, continue 0.85 mg every 6 hours; if it has fallen by less than 30%, the highlights allow increase to 1.7 mg every 6 hours. Continue until 24 hours after two consecutive SCr values <=1.5 mg/dL at least 2 hours apart, or at most 14 days.

Benefit is unlikely above SCr 5 mg/dL. Do not start during hypoxia; monitor continuously and stop if SpO2 falls below 90%. Assess volume status and ACLF grade. This selected pathway does not replace full eligibility, ischemia and respiratory-risk review.

The source says benefit is unlikely when serum creatinine exceeds 5 mg/dL. Obtain baseline oxygen saturation, use continuous pulse oximetry and do not treat unresolved hypoxia. The regimen adjusts to serum-creatinine response rather than a fixed CrCl category.

The selected RX rendering places the complete adjustment pathway in an image. This card therefore preserves eligibility/monitoring only; the separately retrieved official label supplies the dosing pathway. An official supplement does not establish that every RX image or monograph section was recovered.